Minimum trial curation to reasonably assess long-term efficacy of nonhormonal hot flash therapies

Journal of Women's Health

Volumn 19, Issue 4, 2010, Pages 699-702

  Guttuso Jr , Thomas ^a   Evans, Michele ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Huntington Reproductive Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELLERGAL; BELLERGAL RETARD; DESVENLAFAXINE; GABAPENTIN; PAROXETINE; PLACEBO; SOYBEAN OIL; UNCLASSIFIED DRUG; VENLAFAXINE; ESTROGEN;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HOT FLUSH; HUMAN; LONG TERM CARE; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; COMPARATIVE STUDY; FEMALE; HEALTH CARE QUALITY; HOT FLASHES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TIME; TRENDS; WOMEN'S HEALTH;

ESTROGENS; FEMALE; HOT FLASHES; HUMANS; PROCESS ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; WOMEN'S HEALTH;

EID: 77951782809     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1610     Document Type: Article

References (19)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
2. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 2004;291:47-53.
3. European Medicines Agency EMEA. Guideline of clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women. Available at www.emea.europa.eu= pdfs=human=ewp=002197en.pdf Accessed July 15, 2008.
4. U.S. Department of Health and Human Services, FDA. Guidance for Industry: Estrogen and estrogen=progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-Recommendations for clinical evaluation. Available at www.fda.gov=cder=guidance= 5412dft.pdf Accessed July 6, 2008.
5. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health 1985;8:261-268.
6. Bergmans MG, Merkus JM, Corbey RS, Schellekens LA, Ubachs JM. Effect of Bellergal Retard on climacteric complaints: A double-blind, placebo-controlled study. Maturitas 1987;9:227-234.
7. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, doubleblind, randomized, placebo-controlled study. Menopause 2000;7:236-242.
8. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: A randomized, controlled trial. Obstet Gynecol 2005;105:161-166.
9. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2001:CD002978.
10. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial. Obstet Gynecol 2003;101: 337-345.
11. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 2000;356:2059-2063.
12. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet 2005;366: 818-824.
13. Speroff L, Gass M, Constantine G, Olivier S. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial. Obstet Gynecol 2008;111:77-87.
14. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 2003;289:2827-2834.
15. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: A randomized controlled trial. Menopause 2008;15:310-318.
16. Guttuso T, McDermott MP, Su H, Kieburtz K. Effects of l-isoleucine and l-valine on hot flushes and serum homocysteine: A randomized controlled trial. Obstet Gynecol 2008;112:109-115.
17. Reddy SY, Warner H, Guttuso T Jr, et al. Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial. Obstet Gynecol 2006;108:41-48.
18. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: A discussion of trial duration. Menopause 2009;16:883-887.
19. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005; 12:18-26.